Partners Wealth Management’s Gilead Sciences GILD Stock Holding History

Partners Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$272K	Hold	2,150	–	–	0.27%	81
2026 Q1	$300K	Hold	2,150	–	–	0.31%	78
2025 Q4	$264K	Buy	2,150 +61	+3%	+$7.41K	0.28%	89
2025 Q3	$232K	Hold	2,089	–	–	0.23%	107
2025 Q2	$232K	Hold	2,089	–	–	0.26%	99
2025 Q1	$234K	Buy	+2,089	New	+$216K	0.27%	100

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Partners Wealth Management's GILD Position: Q2 2026 in Review

Partners Wealth Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,150 shares worth $272K. The position accounts for 0.27% of the portfolio, ranked #81.

Partners Wealth Management first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $300K in Q1 2026. 615 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Partners Wealth Management held 2,150 shares of Gilead Sciences worth $272K as of Q2 2026.
Partners Wealth Management left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.27% of Partners Wealth Management's portfolio in Q2 2026, its #81 holding.
Partners Wealth Management first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
Partners Wealth Management's Gilead Sciences position peaked at $300K in Q1 2026.
615 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Partners Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.